CCL5 and infection: However, the quantity of CCL5 at 48 and 72 h post infection remained significantly elevated in HIV treated with P3DEX compared to untreated (70.16 ± 5.94 vs. 117.86 ± 12.7 pg/mL; p = 0.02 and 51.6 ± 11.9 vs. 72.94 ± 5.65 pg/mL; p = 0.03, respectively) or DEX-treated (72.24 ± 11.1 vs. 117.86 ± 12.7 pg/mL; p = 0.03 and 53.9 ± 10.7 vs. 72.94 ± 5.65 pg/mL; p = 0.02, respectively) HIV-infected macrophages.